Artwork

Content provided by Ira Pastor. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ira Pastor or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Dr. James Murphy, PhD - Director, Research and Science, British American Tobacco (BAT) - Building A Smokeless World

38:04
 
Share
 

Manage episode 407740010 series 2835025
Content provided by Ira Pastor. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ira Pastor or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Send us a Text Message.

Dr. James Murphy, PhD is Director, Research and Science, at British American Tobacco ( BAT - https://www.bat.com/DOCNLKSF.html ) where he plays a central role in leading the organization’s extensive research and development programs, which supports the company’s commitment to reducing the health impact of its business by offering consumers a range of alternative tobacco and nicotine products with a reduced risk profile. In this role, Dr Murphy leads the global Research and Science team, ensuring world-class science and best practice are applied to all aspects of BAT’s work and helps to deliver further scientific evidence that supports BAT’s New Categories products. Dr. Murphy has played a significant role in the development of BAT’s New Categories having been Product Development Lead for BAT’s first vapour launches and as Head of Reduced Risk Substantiation, he created and published the Group’s nine-step scientific assessment framework to assess BAT’s New Category products. Dr. Murphy brings two decades of experience and has held a number of senior roles in R&D, Operations and Marketing at BAT. He was most recently Executive Vice President, U.S. Scientific Research & Development, based at the headquarters of BAT’s U.S. business in Winston-Salem, North Carolina. Dr. Murphy has a BSc (Hons) in Chemistry from the Queen’s University of Belfast, a PhD in Synthetic Organic Chemistry and Polymer Chemistry from the University of Edinburgh, and did his Postdoctoral Studies in Sugar Based Synthetic Organic Chemistry Polymer Chemistry, at the Nara Institute of Science and Technology in Japan. Disclaimer: Reduced-risk product statements in this podcast are based on the weight of evidence and assuming a complete switch from cigarette smoking. These products are not risk-free and are addictive. BAT's products as sold in the U.S., including Vuse, Velo, Grizzly, Kodiak, and Camel Snus, are subject to Food and Drug Administration (FDA) regulation and no reduced-risk claims will be made as to these products without FDA clearance.

Support the Show.

  continue reading

540 episodes

Artwork
iconShare
 
Manage episode 407740010 series 2835025
Content provided by Ira Pastor. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ira Pastor or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Send us a Text Message.

Dr. James Murphy, PhD is Director, Research and Science, at British American Tobacco ( BAT - https://www.bat.com/DOCNLKSF.html ) where he plays a central role in leading the organization’s extensive research and development programs, which supports the company’s commitment to reducing the health impact of its business by offering consumers a range of alternative tobacco and nicotine products with a reduced risk profile. In this role, Dr Murphy leads the global Research and Science team, ensuring world-class science and best practice are applied to all aspects of BAT’s work and helps to deliver further scientific evidence that supports BAT’s New Categories products. Dr. Murphy has played a significant role in the development of BAT’s New Categories having been Product Development Lead for BAT’s first vapour launches and as Head of Reduced Risk Substantiation, he created and published the Group’s nine-step scientific assessment framework to assess BAT’s New Category products. Dr. Murphy brings two decades of experience and has held a number of senior roles in R&D, Operations and Marketing at BAT. He was most recently Executive Vice President, U.S. Scientific Research & Development, based at the headquarters of BAT’s U.S. business in Winston-Salem, North Carolina. Dr. Murphy has a BSc (Hons) in Chemistry from the Queen’s University of Belfast, a PhD in Synthetic Organic Chemistry and Polymer Chemistry from the University of Edinburgh, and did his Postdoctoral Studies in Sugar Based Synthetic Organic Chemistry Polymer Chemistry, at the Nara Institute of Science and Technology in Japan. Disclaimer: Reduced-risk product statements in this podcast are based on the weight of evidence and assuming a complete switch from cigarette smoking. These products are not risk-free and are addictive. BAT's products as sold in the U.S., including Vuse, Velo, Grizzly, Kodiak, and Camel Snus, are subject to Food and Drug Administration (FDA) regulation and no reduced-risk claims will be made as to these products without FDA clearance.

Support the Show.

  continue reading

540 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide